Sitagliptin/Metformin Fed Bioequivalence Study (0431A-080)
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
This study will demonstrate the bioequivalence of metformin after single dose administration
of sitagliptin/metformin 50/500 mg fixed dose combination (FDC) tablet and concomitant
administration of single doses of sitagliptin 50 mg and metformin 500 mg as individual
tablets after consumption of a high-fat meal.